The Beckley Foundation and its founder and long-time psychedelics researcher Amanda Feilding announced a new research program involving a pioneering study with King's College London and UCL on the ...

LSD usage is on the rise among U.S. adults – especially young adults with depression. And the trend mirrors growing research into the psychedelic drug's ability to treat mental health disorders like ...

A clinical trial’s encouraging results won US Food and Drug Administration breakthrough therapy status for an LSD formulation to treat generalized anxiety disorder, Mind Medicine Inc. announced ...

The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy status to an LSD formula to treat generalized anxiety disorder after an initial study has shown that a single dose of the ...

For a couple of freewheeling years, two young Harvard psychologists have carried on wide-ranging experiments with mind-altering drugs. At the university’s Center for Research in Personality, they sent ...

The Beckley Foundation and its founder Amanda Feilding announced a new research program with King's College London and UCL on the effects of full dose LSD as well as a breakthrough study with the ...

A series of three new research projects announced this week will seek to illuminate our understanding of microdosing LSD. The research is being spearheaded by The Beckley Foundation and its founder, ...

What a long, strange trip it's been for psychedelics. Natural substances like peyote, ayahausca, and psilocybin from mushrooms were traditionally used in ancient cultures, often in religious ...

A New York-based biotech firm has begun a clinical trial to study LSD as a treatment for anxiety, announcing last week that it had administered the psychedelic drug to a patient enrolled in the study ...

In 1966, psychedelic drug advocate and former Harvard professor Timothy Leary appeared on the Merv Griffin Show. "I'm in the unfortunate situation of being about 20 years ahead of my time," Leary said ...